Cargando…
Drivers of COVID-19 vaccinations: vaccine delivery and delivery efficiency in the United States
This paper adds some formal research to the success of ongoing efforts to combat the COVID-19 pandemic by examining the drivers of the administration and delivery efficiency of coronavirus vaccines. For this purpose, we use data from the 50 US states and place the formal analysis in the context of s...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211434/ http://dx.doi.org/10.1007/s11066-021-09148-w |
_version_ | 1783709464270995456 |
---|---|
author | Goel, Rajeev K. Nelson, Michael A. |
author_facet | Goel, Rajeev K. Nelson, Michael A. |
author_sort | Goel, Rajeev K. |
collection | PubMed |
description | This paper adds some formal research to the success of ongoing efforts to combat the COVID-19 pandemic by examining the drivers of the administration and delivery efficiency of coronavirus vaccines. For this purpose, we use data from the 50 US states and place the formal analysis in the context of socio-economic drivers of vaccinations. Results show that state-economic prosperity and rural population aid vaccine administration and delivery efficiency. Delivery efficiency improves in states with more nursing homes per capita, in states with more COVID-19 deaths, and with more health workers. A subset of health workers, including physicians and nurses, did not significantly impact administration or efficiency. On the other hand, vaccination efficiency was lower in states with a centralized public health agency. States with a larger share of the elderly population and those with Democrats as governors were no different from others with regard to vaccinations. Robustness checks are performed using vaccination data from a more recent period. Finally, a state’s legacy of corrupt activity, across two different time dimensions, is broadly consistent with the greasing effects of corruption. Some policy implications based on the evolving data are discussed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11066-021-09148-w. |
format | Online Article Text |
id | pubmed-8211434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-82114342021-06-21 Drivers of COVID-19 vaccinations: vaccine delivery and delivery efficiency in the United States Goel, Rajeev K. Nelson, Michael A. Netnomics Article This paper adds some formal research to the success of ongoing efforts to combat the COVID-19 pandemic by examining the drivers of the administration and delivery efficiency of coronavirus vaccines. For this purpose, we use data from the 50 US states and place the formal analysis in the context of socio-economic drivers of vaccinations. Results show that state-economic prosperity and rural population aid vaccine administration and delivery efficiency. Delivery efficiency improves in states with more nursing homes per capita, in states with more COVID-19 deaths, and with more health workers. A subset of health workers, including physicians and nurses, did not significantly impact administration or efficiency. On the other hand, vaccination efficiency was lower in states with a centralized public health agency. States with a larger share of the elderly population and those with Democrats as governors were no different from others with regard to vaccinations. Robustness checks are performed using vaccination data from a more recent period. Finally, a state’s legacy of corrupt activity, across two different time dimensions, is broadly consistent with the greasing effects of corruption. Some policy implications based on the evolving data are discussed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11066-021-09148-w. Springer US 2021-06-17 2021 /pmc/articles/PMC8211434/ http://dx.doi.org/10.1007/s11066-021-09148-w Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Goel, Rajeev K. Nelson, Michael A. Drivers of COVID-19 vaccinations: vaccine delivery and delivery efficiency in the United States |
title | Drivers of COVID-19 vaccinations: vaccine delivery and delivery efficiency in the United States |
title_full | Drivers of COVID-19 vaccinations: vaccine delivery and delivery efficiency in the United States |
title_fullStr | Drivers of COVID-19 vaccinations: vaccine delivery and delivery efficiency in the United States |
title_full_unstemmed | Drivers of COVID-19 vaccinations: vaccine delivery and delivery efficiency in the United States |
title_short | Drivers of COVID-19 vaccinations: vaccine delivery and delivery efficiency in the United States |
title_sort | drivers of covid-19 vaccinations: vaccine delivery and delivery efficiency in the united states |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211434/ http://dx.doi.org/10.1007/s11066-021-09148-w |
work_keys_str_mv | AT goelrajeevk driversofcovid19vaccinationsvaccinedeliveryanddeliveryefficiencyintheunitedstates AT nelsonmichaela driversofcovid19vaccinationsvaccinedeliveryanddeliveryefficiencyintheunitedstates |